14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
HSTM vs WORX
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HSTM vs WORX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HSTM Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 10–0 Matrix Metrics)
HSTM Overall Winner
6-Pillar Tally: HSTM 4 – 1 WORX (1 Tie)
Matrix Metrics: HSTM 10 – 0 WORX
As of Nov 16, 2026, HealthStream Inc (HSTM) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HSTM carries a Unified Composite Score of 55.8/100 (HOLD) at $27.68 (30.1x Forward P/E, 7.8% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin).
HSTM
NASDAQ
Head-to-Head Winner
HealthStream Inc
Services-Computer Programming, Data Processing, Etc.
Market Cap
$855.8M
TTM Revenue
$328M
Forward P/E
30.1x
Beta / 30D Vol
0.39β · 48% Vol
Unified Composite Score
55.8 / 100
HOLD
Tech 45.0
Fund 50.0
Flow 50.0
Mom 55.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 28
RSI-14: 28.5 · SMA20: $31.74 · SMA50: $31.07
WORX
NASDAQ
SC WORX Corp
Services-Computer Processing & Data Preparation
Market Cap
$1.7M
TTM Revenue
$2.9M
Forward P/E
N/M
Beta / 30D Vol
23.01β · 208% Vol
Unified Composite Score
34.1 / 100
SELL
Tech 15.0
Fund 31.0
Flow 50.0
Mom 30.0
Weinstein Technical Phase
Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 71
RSI-14: 71.4 · SMA20: $0.24 · SMA50: $0.24
6-Pillar Scorecard Institutional Category Breakdown (HSTM 4 – 1 WORX)
Columns: Metric · HSTM · WORX
1. Valuation Multiples
HSTM
Forward P/E
30.1x
N/M
Trailing P/E
40.0x
N/M
PEG Ratio
2.95x
N/M
EV / Revenue
2.6x
0.6x
2. Growth & Scale
HSTM
Revenue Growth (YoY)
+8.9%
+3.4%
Earnings Growth (YoY)
-10.0%
+0.0%
TTM Revenue (USD)
$328M
$2.9M
Market Cap
$855.8M
$1.7M
3. Profitability & Quality
HSTM
Gross Margin
64.7%
44.7%
Operating Margin
7.8%
-20.1%
Net Profit Margin
6.2%
-80.5%
Return on Equity (ROE)
5.5%
-38.1%
4. Balance Sheet & Cash Flow
HSTM
Cash Generation (TTM)
$45M EBITDA
-$914,262
Cash Flow Margin
13.6% EBITDA Mgn
-31.2%
Net Cash / Leverage
$13.13 Book/Sh · 5.5% ROE
$77.66 Book/Sh · -38.1% ROE
Dividend Yield
0.48%
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
21.1% (50th %ile)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
WORX
OpEx & R&D Intensity
56.9% of Rev ($187M)
64.8% of Rev ($1.9M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Health Information Services Operator
Health Information Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HSTM (10) vs WORX (0)
Institutional Metric
HSTM
WORX
Criterion
Row Edge
Market Capitalization
Scale
$855.8M
$1.7M
Larger Scale
HSTM
Trailing P/E Ratio
Valuation
40.0x
N/M
Lower Multiple
HSTM
Forward P/E Ratio
Valuation
30.1x
N/M
Lower Multiple
HSTM
Revenue Growth (YoY)
Growth
+8.9%
+3.4%
Higher Growth
HSTM
Operating Margin (TTM)
Profitability
7.8%
-20.1%
Higher Margin
HSTM
Net Profit Margin
Profitability
6.2%
-80.5%
Higher Margin
HSTM
Return on Equity (ROE)
Capital Efficiency
5.5%
-38.1%
Higher ROE
HSTM
52-Week Range Position
Momentum
51% ($20–$36)
17% ($0–$6)
Stronger Trend
HSTM
Beta / 30D Volatility
Risk Regime
0.39β · 48% Vol
23.01β · 208% Vol
Lower Realized Risk
HSTM
Unified Institutional Score
Composite Signal
55.8 / 100 (HOLD)
34.1 / 100 (SELL)
Higher Composite
HSTM
Trailing 12M Revenue (USD)
Operating Scale
$328M
$2.9M
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.7%
44.7%
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.95x PEG · 2.6x EV/Rev
N/M PEG · 0.6x EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$45M EBITDA ($13.13 Book/Sh · 5.5% ROE)
-$914,262 ($77.66 Book/Sh · -38.1% ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
HSTM +0.22 pp
HSTM:
-16.45%
·
WORX:
-16.67%
3M Horizon
WORX +198.06 pp
HSTM:
+30.32%
·
WORX:
+228.38%
6M Horizon
WORX +314.92 pp
HSTM:
+12.43%
·
WORX:
+327.35%
1Y Horizon
WORX +250.12 pp
HSTM:
+12.66%
·
WORX:
+262.78%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HSTM vs WORX. Trailing 12-month operating profitability (HSTM 7.8% vs WORX -20.1%) and valuation multiples (HSTM 30.1x vs WORX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
HSTM ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $328M
Gross Margin 64.7%
Op. Margin 7.8%
ROE / Fwd P/E 5.5% · 30.1x
WORX ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $2.9M
Gross Margin 44.7%
Op. Margin -20.1%
ROE / Fwd P/E -38.1% · N/M
HSTM
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
21.1%
IV Percentile
50th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
WORX
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
HSTM Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $855.8M market capitalization and 7.8% operating margin.
OpEx & R&D Reinvestment
56.9% of Rev ($187M)
90D Engineering Disclosures
0 Published
WORX Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $1.7M market capitalization and -20.1% operating margin.
OpEx & R&D Reinvestment
64.8% of Rev ($1.9M)
90D Engineering Disclosures
0 Published
Investor FAQ HSTM vs WORX Key Questions & Quantitative Answers
Is HSTM or WORX a better stock to buy right now?
As of Nov 16, 2026, HealthStream Inc (HSTM) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HSTM carries a Unified Composite Score of 55.8/100 (HOLD) at $27.68 (30.1x Forward P/E, 7.8% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin). Technically, HSTM sits in a Neutral phase (RSI 28.5, UNCLASSIFIED options structure) and WORX sits in a Markup phase (RSI 71.4, UNCLASSIFIED options structure).
Does HSTM or WORX have stronger revenue and earnings growth?
HSTM leads the Growth & Scale pillar: HSTM posts +8.9% YoY revenue growth and -10.0% YoY earnings growth on $328M TTM revenue (64.7% gross margin, 7.8% operating margin), compared with WORX at +3.4% YoY revenue growth and +0.0% YoY earnings growth on $2.9M TTM revenue (44.7% gross margin, -20.1% operating margin). On trailing 12-month operating scale, HSTM generates $328M in USD-normalized revenue versus $2.9M for WORX. In operating R&D and SG&A reinvestment, HSTM deploys 56.9% of Rev ($187M) (0 90-day corporate R&D disclosures) versus 64.8% of Rev ($1.9M) (0 disclosures) for WORX.
Is HSTM or WORX cheaper on valuation?
HSTM screens cheaper on headline valuation multiples. HSTM trades at 30.1x Forward P/E, 40.0x Trailing P/E, 2.95x PEG, and 2.6x EV/Revenue (13.6% EBITDA margin), whereas WORX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-31.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HSTM (5.5% ROE) versus WORX (-38.1% ROE) capital efficiency.
How is options market volatility positioned on HSTM vs WORX?
In options market volatility and institutional positioning, HSTM carries 21.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.39β · 48% Vol realized risk). By comparison, WORX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.01β · 208% Vol realized risk).
HealthStream Inc (HSTM) Research Suite
SC WORX Corp (WORX) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.